Patents by Inventor Monte Browder

Monte Browder has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Oral extended-release composition
    Patent number: 8628797
    Abstract: The invention is directed to controlled release formulations containing drugs which are preferably considered sparingly soluble to insoluble and which are suitable for administration to a patient in need of treatment related thereto, and methods of manufacturing the same.
    Type: Grant
    Filed: December 3, 2008
    Date of Patent: January 14, 2014
    Assignee: Andrx Pharmaceuticals, LLC
    Inventors: Boying Li, Avinash Nangia, Monte Browder
  • ORAL EXTENDED-RELEASE COMPOSITION
    Publication number: 20090124563
    Abstract: The invention is directed to controlled release formulations containing drugs which are preferably considered sparingly soluble to insoluble and which are suitable for administration to a patient in need of treatment related thereto, and methods of manufacturing the same.
    Type: Application
    Filed: December 3, 2008
    Publication date: May 14, 2009
    Inventors: Boying Li, Avinash Nangia, Monte Browder
  • Oral extended-release composition
    Patent number: 7476403
    Abstract: The invention is directed to controlled release formulations containing drugs which are preferably considered sparingly soluble to insoluble and which are suitable for administration to a patient in need of treatment related thereto, and methods of manufacturing the same.
    Type: Grant
    Filed: June 16, 2004
    Date of Patent: January 13, 2009
    Assignee: Andrx Pharmaceuticals, LLC
    Inventors: Boyong Li, Avinash Nangia, Monte Browder
  • Oral extended-release composition
    Publication number: 20050064034
    Abstract: The invention is directed to controlled release formulations containing drugs which are preferably considered sparingly soluble to insoluble and which are suitable for administration to a patient in need of treatment related thereto, and methods of manufacturing the same.
    Type: Application
    Filed: June 16, 2004
    Publication date: March 24, 2005
    Applicant: ANDRX PHARMACEUTICALS, LLC
    Inventors: Boyong Li, Avinash Nangia, Monte Browder